Literature DB >> 11400872

High-energy shock wave treatment of femoral head necrosis in adults.

J Ludwig1, S Lauber, H J Lauber, U Dreisilker, R Raedel, H Hotzinger.   

Abstract

Adults with Stages I to III osteonecrosis of the femoral head present an overall therapeutic challenge. The objective of the current prospective study was to show the effectiveness of high-energy shock wave therapy in treatment of patients with Association Research Circulation Osseous Stage I to Stage III necrosis of the femoral head by assessing clinical and magnetic resonance imaging results. The current study presents the results of 22 patients with femoral head necrosis 1 year after shock wave treatment. The study population consisted of 10 women and 12 men with an average age of 54.9 years (+/- 12.3). The scores achieved on the visual pain analog scale decreased from 8.5 before treatment to 1.2 after 1 year. Simultaneously, the Harris hip score increased from 43.3 to 92 points. Magnetic resonance imaging visualization of a distinct zone of sclerosis around the necrotic area remaining after treatment with extracorporeal shock wave therapy indicated therapeutic failure. The results obtained so far with high-energy shock wave therapy in these patients suggest that this method may offer an alternative to invasive treatment modalities for femoral head necrosis. A noninvasive and moderately priced method then would be available for the treatment of femoral head necrosis in the early stages of the disease process.

Entities:  

Mesh:

Year:  2001        PMID: 11400872     DOI: 10.1097/00003086-200106000-00016

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  43 in total

1.  Does extracorporeal shock wave therapy enhance healing of osteochondritis dissecans of the rabbit knee?: a pilot study.

Authors:  Roger Lyon; Xue Cheng Liu; Martin Kubin; Joseph Schwab
Journal:  Clin Orthop Relat Res       Date:  2013-04       Impact factor: 4.176

Review 2.  [Pharmacotherapeutic aspects of femoral head necrosis].

Authors:  I H Tarner; R Dinser; U Müller-Ladner
Journal:  Orthopade       Date:  2007-05       Impact factor: 1.087

3.  Acoustic field characterization of the Duolith: measurements and modeling of a clinical shock wave therapy device.

Authors:  Camilo Perez; Hong Chen; Thomas J Matula; Maria Karzova; Vera A Khokhlova
Journal:  J Acoust Soc Am       Date:  2013-08       Impact factor: 1.840

4.  Comparison of core decompression and conservative treatment for avascular necrosis of femoral head at early stage: a meta-analysis.

Authors:  Yu-Cai Hong; Hui-Ming Zhong; Tiao Lin; Jian-Bin Shi
Journal:  Int J Clin Exp Med       Date:  2015-04-15

5.  SAS weekly rounds: avascular necrosis.

Authors:  Thomas W Hamilton; Susan M Goodman; Mark Figgie
Journal:  HSS J       Date:  2009-03-18

Review 6.  The use of extracorporeal shock waves in the treatment of osteonecrosis of the femoral head: a systematic review.

Authors:  Eneida Machado Alves; Adriano Tanajura Angrisani; Mittermayer B Santiago
Journal:  Clin Rheumatol       Date:  2009-07-17       Impact factor: 2.980

7.  Study of rotating permanent magnetic field to treat steroid-induced osteonecrosis of femoral head.

Authors:  Xiaohua Pan; Deming Xiao; Xiaoyun Zhang; YuanShuai Huang; Bowen Lin
Journal:  Int Orthop       Date:  2008-01-18       Impact factor: 3.075

Review 8.  [Pain management in non-juvenile, aseptic osteonecrosis].

Authors:  M Jäger; A Werner; S Lentrodt; U Mödder; R Krauspe
Journal:  Schmerz       Date:  2004-12       Impact factor: 1.107

9.  Effectiveness of extracorporeal shock wave therapy in bone marrow edema syndrome of the hip.

Authors:  Cristina d'Agostino; Pietro Romeo; Vito Lavanga; Salvatore Pisani; Valerio Sansone
Journal:  Rheumatol Int       Date:  2014-11       Impact factor: 2.631

10.  Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years.

Authors:  Sokratis E Varitimidis; Apostolos P Dimitroulias; Theophilos S Karachalios; Zoe H Dailiana; Konstantinos N Malizos
Journal:  Acta Orthop       Date:  2009-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.